Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

BSX

Boston Scientific Corp

Feb 21 • 04:00PM ET

104.49

Dollar change -0.87
Percentage change -0.83	%

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO SPY IVV VUG XLV IHI VHT IWD IVW

Index	S&P 500	P/E	83.76	EPS (ttm)	1.25	Insider Own	0.48%	Shs Outstand	1.47B	Perf Week	-1.55%
Market Cap	154.20B	Forward P/E	32.04	EPS next Y	3.26	Insider Trans	-11.49%	Shs Float	1.47B	Perf Month	4.17%
Income	1.85B	PEG	6.19	EPS next Q	0.67	Inst Own	91.89%	Short Float	0.71%	Perf Quarter	15.52%
Sales	16.75B	P/S	9.21	EPS this Y	13.89%	Inst Trans	-0.09%	Short Ratio	1.93	Perf Half Y	33.14%
Book/sh	14.76	P/B	7.08	EPS next Y	14.09%	ROA	4.97%	Short Interest	10.45M	Perf Year	57.79%
Cash/sh	0.36	P/C	293.72	EPS next 5Y	13.54%	ROE	9.03%	52W Range	65.33 - 107.17	Perf YTD	16.98%
Dividend Est.	-	P/FCF	58.30	EPS past 5Y	-17.84%	ROI	5.95%	52W High	-2.50%	Beta	0.78
Dividend TTM	-	Quick Ratio	0.64	Sales past 5Y	9.77%	Gross Margin	61.44%	52W Low	59.93%	ATR (14)	1.66
Dividend Ex-Date	-	Current Ratio	1.08	EPS Y/Y TTM	16.84%	Oper. Margin	15.85%	RSI (14)	63.45	Volatility	1.44% 1.57%
Employees	53000	Debt/Eq	0.52	Sales Y/Y TTM	17.60%	Profit Margin	11.07%	Recom	1.39	Target Price	119.06
Option/Short	Yes / Yes	LT Debt/Eq	0.43	EPS Q/Q	11.28%	Payout	0.00%	Rel Volume	1.02	Prev Close	105.36
Sales Surprise	3.18%	EPS Surprise	6.53%	Sales Q/Q	22.44%	Earnings	Feb 05 BMO	Avg Volume	5.41M	Price	104.49
SMA20	0.11%	SMA50	7.34%	SMA200	23.07%	Trades		Volume	5,512,563	Change	-0.83%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$51
May-26-21	Downgrade	Needham	Buy → Hold
May-25-21	Initiated	Barclays	Overweight	$51
Apr-15-21	Initiated	Atlantic Equities	Overweight	$52

Show Previous Ratings

Feb-21-25 09:35PM	Boston Scientific announces pricing of 1.5 billion of senior notes (PR Newswire)
Feb-19-25 10:01AM	Solid Company Fundamentals Lifted Boston Scientific Corporation (BSX) (Insider Monkey)
08:07AM	Baxter Earnings: What To Look For From BAX (StockStory)
08:00AM	Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference (PR Newswire)
Feb-17-25 11:31AM	Boston Scientific bags CE marking for Farapulse catheter and software (Medical Device Network)
09:41AM	Loading…
Feb-14-25 09:41AM	Boston Scientific Corporation (BSX): Among the Best Momentum Stocks to Buy According to Hedge Funds (Insider Monkey)
08:00AM	J&Js High Hopes for Heart-Rhythm Device Grounded by Safety Concerns (The Wall Street Journal)
Feb-12-25 09:19AM	Why Boston Scientific Corporation (BSX) is the Best Medical Device Stock to Buy (Insider Monkey)
08:05AM	What To Expect From Baxters (BAX) Q4 Earnings (StockStory)
Feb-10-25 12:55PM	Globus Medical strengthens SCS market position with $250m Nevro deal (Medical Device Network)
04:04AM	Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX) (StockStory)
Feb-07-25 12:00PM	Boston Scientific (BSX) is a Great Momentum Stock: Should You Buy? (Zacks)
09:40AM	Has Boston Scientific (BSX) Outpaced Other Medical Stocks This Year? (Zacks)
Feb-06-25 11:42AM	Farapulse boosts Boston Scientifics Q4 electrophysiology sales by 172% (Medical Device Network)
09:45AM	Here's Why Boston Scientific (BSX) is a Strong Growth Stock (Zacks)
02:06AM	Loading…
02:06AM	Boston Scientific Corp (BSX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strong ... (GuruFocus.com)
12:40AM	Q4 2024 Boston Scientific Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-05-25 04:32PM	How Boston Sci Leaned On Its New Heart Device For A Fourth-Quarter Beat (Investor's Business Daily)
03:43PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
09:30AM	Boston Scientific (BSX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:57AM	Boston Scientific Beats Its Own Fourth-Quarter Guidance On Cardiovascular Strength (Investor's Business Daily)
07:45AM	Boston Scientific (BSX) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
07:24AM	Boston Scientific reports above-consensus Q4 results, provides outlook (Investing.com)
06:56AM	Boston Scientific closes its year of PFA on a high note (MedTech Dive)
06:50AM	Boston Scientific (NYSE:BSX) Reports Bullish Q4, Guides for Strong Sales Next Quarter (StockStory)
06:49AM	Boston Scientific: Q4 Earnings Snapshot (Associated Press Finance)
06:37AM	Boston Scientific announces results for fourth quarter and full year 2024 (PR Newswire)
Feb-03-25 01:06PM	TD Cowen Raises Boston Scientific Corporation (BSX) Target to $115, Reaffirms Buy Rating Ahead of Q4 Results (Insider Monkey)
Feb-01-25 09:05AM	Boston Scientific price target raised to $119 from $101 at Raymond James (TipRanks)
Jan-31-25 09:15AM	What Analyst Projections for Key Metrics Reveal About Boston Scientific (BSX) Q4 Earnings (Zacks)
10:01AM	Loading…
Jan-29-25 10:01AM	Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-28-25 06:09AM	US pulsed field ablation market revenue exceeds $500m in 2024 (Medical Device Network)
Jan-27-25 06:00PM	Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
07:49AM	Is Boston Scientific (BSX) Among the Best Fundamental Stocks to Buy Now? (Insider Monkey)
06:27AM	Doctors expect Boston Scientific to lead PFA race, survey finds (MedTech Dive)
Jan-24-25 12:03PM	Boston Scientific Corp (BSX): AI-Driven Innovation and Barclays Bullish $111 Price Target (Insider Monkey)
Jan-23-25 06:15PM	Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-21-25 05:21PM	Is Boston Scientific (BSX) Among Billionaire Steve Cohens Top Stock Picks? (Insider Monkey)
06:38AM	Boston Scientific study meets goals for PFA in persistent AFib (MedTech Dive)
Jan-20-25 08:06AM	Boston Scientific sees success in PFA device trial (Clinical Trials Arena)
Jan-17-25 06:00PM	Boston Scientific (BSX) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Jan-16-25 05:33PM	Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation (PR Newswire)
Jan-15-25 06:10AM	Boston Scientific Jumps Ahead of Earnings (FX Empire)
Jan-14-25 11:30PM	Boston Scientific ups PFA forecast, targets market leadership (MedTech Dive)
Jan-13-25 06:15PM	Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
04:01PM	Why Boston Scientific (BSX) is Skyrocketing in 2025? (Insider Monkey)
Jan-10-25 01:13PM	Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific (CNBC TV)
Jan-09-25 05:52AM	5 medtech trends to watch in 2025 (MedTech Dive)
05:16AM	Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m (Medical Device Network)
04:29AM	Boston Scientific Completes Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio (GuruFocus.com)
Jan-08-25 10:21PM	Here's Why Boston Scientific Corp. (BSX) Skyrocketed Today (Insider Monkey)
07:06PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
05:23PM	S+P 500 Gains and Losses Today: eBay Soars as Meta Permits Facebook Marketplace Listings (Investopedia)
04:08PM	Boston Scientific Surges On $900 Million Takeover Of Bolt Medical (Investor's Business Daily)
04:07PM	J&J Falls While Boston Scientific, Medtronic Pop After Strokes Sideline A Key Product (Investor's Business Daily)
04:00PM	Boston Scientific acquiring Bolt Medical in $443 million deal (Yahoo Finance Video)
12:45PM	Top Stock Movers Now: EBay, Cal-Maine Foods, AMD, and More (Investopedia)
12:25PM	Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal (Benzinga)
12:14PM	Boston Scientific to Acquire Bolt Medical for $443 Million in Expansion of Cardiovascular Portfolio (GuruFocus.com)
10:16AM	Boston Scientific Surges Into Buy Zone On $900 Million Takeover Of Bolt Medical (Investor's Business Daily)
09:15AM	Boston Scientific Corporation (BSX) Hits Fresh High: Is There Still Room to Run? (Zacks)
07:00AM	Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc. (PR Newswire)
Jan-07-25 06:00PM	Boston Scientific (BSX) Gains As Market Dips: What You Should Know (Zacks)
Jan-06-25 06:15PM	Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know (Zacks)
09:40AM	Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
09:00AM	Sherpa Healthcare Partners Appoints Veteran MedTech Executive Raymond W. Cohen as Venture Partner (PR Newswire)
08:09AM	Is Boston Scientific Corporation (NYSE:BSX) Among Israel Englanders Top Stock Picks Heading Into 2025? (Insider Monkey)
Jan-03-25 06:46AM	Boston Scientific price target raised to $100 from $95 at Evercore ISI (TipRanks)
Jan-02-25 08:00AM	Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results (PR Newswire)
05:42AM	Top 10 medtech deals of 2024 (MedTech Dive)
Jan-01-25 12:10PM	Why Boston Scientific (BSX) is Poised to Beat Earnings Estimates Again (Zacks)
Dec-31-24 06:00PM	Boston Scientific (BSX) Stock Moves -0.4%: What You Should Know (Zacks)
07:05AM	Boston Scientific price target raised to $101 from $97 at BTIG (TipRanks)
Dec-30-24 06:15PM	Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Dec-28-24 08:00AM	S&P 500 Winners Fortinet, Boston Scientific Lead 5 Stocks Near Buy Points (Investor's Business Daily)
Dec-26-24 04:56PM	Boston Scientific, IBD Stock Of The Day, Has Surged 57% In 2024. This Is Why There's More Upside. (Investor's Business Daily)
04:40PM	Stocks Hold In Quiet Day; Burlington Stores, Boston Scientific, Vertex Inc. In Focus (Investor's Business Daily)
Dec-24-24 06:00PM	Why Boston Scientific (BSX) Outpaced the Stock Market Today (Zacks)
Dec-23-24 06:15PM	Boston Scientific (BSX) Rises Higher Than Market: Key Facts (Zacks)
Dec-19-24 12:00PM	All You Need to Know About Boston Scientific (BSX) Rating Upgrade to Buy (Zacks)
07:30AM	Boston Scientific price target raised to $110 from $100 at Truist (TipRanks)
04:56AM	Boston Scientific updates cryoablation catheter instructions after 4 death reports (MedTech Dive)
Dec-17-24 06:00PM	Boston Scientific (BSX) Stock Moves -0.03%: What You Should Know (Zacks)
07:24AM	Boston Scientific recalls Accolade pacemakers tied to 2 deaths (MedTech Dive)
Dec-16-24 07:12AM	PFA to surpass radiofrequency ablation in 2025: Citi survey (MedTech Dive)
Dec-13-24 11:10PM	Jim Cramer on Boston Scientific Corporation (BSX): A Superior Company (Insider Monkey)
09:30AM	Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Dec-11-24 06:00PM	Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
08:08AM	Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace (PR Newswire)
Dec-05-24 06:00PM	Boston Scientific (BSX) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Nov-26-24 09:30AM	Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet (Zacks)
07:05AM	Boston Scientific to acquire Intera Oncology, terms not disclosed (TipRanks)
Nov-25-24 12:16PM	Boston Scientific expands infusion offerings with Intera Oncology acquisition (Medical Device Network)
07:00AM	Boston Scientific Announces Agreement to Acquire Intera Oncology Inc. (PR Newswire)
06:46AM	Boston Scientific to buy Intera Oncology, maker of liver cancer treatment (MedTech Dive)
Nov-22-24 11:30AM	Why Is Boston Scientific (BSX) Up 7.5% Since Last Earnings Report? (Zacks)
Nov-20-24 10:20AM	Boston Scientific Corporation (BSX)s Breakthroughs: A Hidden Gem in Billionaire Ken Griffins Portfolio (Insider Monkey)
Nov-18-24 10:00AM	Inside a $400 billion bet on the brain-computer interface revolution (Yahoo Finance)
06:57AM	Boston Scientifics Watchman could be new option for patients post ablation: study (MedTech Dive)
06:48AM	The PFA race is heating up. Heres where the market stands after J&Js approval. (MedTech Dive)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '25	Option Exercise	0.00	2,776	0	32,477	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 14 '25	Option Exercise	0.00	16,524	0	1,643,475	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 14 '25	Option Exercise	0.00	4,362	0	179,108	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16 '25	Option Exercise	0.00	3,960	0	181,078	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17 '25	Option Exercise	0.00	4,167	0	183,439	Feb 18 05:52 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 14 '25	Option Exercise	0.00	3,172	0	20,935	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16 '25	Option Exercise	0.00	2,546	0	21,947	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '25	Option Exercise	0.00	2,834	0	23,550	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 14 '25	Option Exercise	0.00	1,850	0	50,101	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 16 '25	Option Exercise	0.00	1,839	0	51,045	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 17 '25	Option Exercise	0.00	1,000	0	51,155	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 14 '25	Option Exercise	0.00	4,362	0	247,700	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 16 '25	Option Exercise	0.00	4,243	0	249,833	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 17 '25	Option Exercise	0.00	4,584	0	252,365	Feb 18 05:50 PM
JOHN B SORENSON	Officer	Feb 18 '25	Proposed Sale	104.41	2,657	277,417		Feb 18 04:09 PM
DANIEL BRENNAN	Officer	Feb 18 '25	Proposed Sale	104.57	17,530	1,833,184		Feb 18 04:09 PM
Carruthers Wendy	Officer	Feb 14 '25	Proposed Sale	106.45	9,393	999,911		Feb 14 05:32 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 12 '25	Option Exercise	0.00	480	0	3,437	Feb 14 05:30 PM
Sorenson John Bradley	EVP, Global Operations	Feb 12 '25	Option Exercise	0.00	1,731	0	26,024	Feb 14 05:30 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 12 '25	Option Exercise	0.00	961	0	12,917	Feb 14 05:30 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 12 '25	Option Exercise	0.00	65	0	1,567	Feb 14 05:30 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 12 '25	Option Exercise	0.00	2,115	0	30,569	Feb 14 05:29 PM
Mahoney Michael F	Chairman, President & CEO	Feb 12 '25	Option Exercise	0.00	13,704	0	1,633,577	Feb 14 05:29 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 12 '25	Option Exercise	0.00	3,462	0	176,325	Feb 14 05:29 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 12 '25	Option Exercise	0.00	2,692	0	18,713	Feb 14 05:29 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 12 '25	Option Exercise	0.00	1,442	0	48,675	Feb 14 05:28 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Option Exercise	0.00	3,654	0	245,105	Feb 14 05:28 PM
JOHN B SORENSON	Officer	Feb 14 '25	Proposed Sale	106.31	1,201	127,678		Feb 14 04:02 PM
Sorenson John Bradley	EVP, Global Operations	Feb 12 '25	Sale	105.06	6,389	671,249	24,293	Feb 13 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 12 '25	Sale	105.06	13,022	1,368,073	28,454	Feb 13 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Dec 03 '24	Buy	90.29	50	4,515	148,168	Feb 13 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Dec 10 '24	Sale	89.97	20	1,799	148,148	Feb 13 04:32 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Option Exercise	16.31	15,087	246,069	256,538	Feb 13 04:31 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Sale	105.07	15,087	1,585,135	241,451	Feb 13 04:31 PM
LUDWIG EDWARD J	Director	Feb 11 '25	Sale	105.48	12,000	1,265,815	24,398	Feb 12 07:30 PM
DANIEL BRENNAN	Officer	Feb 12 '25	Proposed Sale	105.07	15,087	1,585,135		Feb 12 04:04 PM
JEFFREY B MIRVISS	Officer	Feb 12 '25	Proposed Sale	105.06	13,022	1,368,073		Feb 12 04:04 PM
JOHN B SORENSON	Officer	Feb 12 '25	Proposed Sale	105.06	6,389	671,249		Feb 12 04:03 PM
LUDWIG EDWARD J	Director	Feb 11 '25	Proposed Sale	105.48	12,000	1,265,816		Feb 11 05:42 PM
Sorenson John Bradley	EVP, Global Operations	Feb 07 '25	Sale	104.97	6,528	685,244	26,449	Feb 10 04:48 PM
JOHN B SORENSON	Officer	Feb 07 '25	Proposed Sale	104.97	6,528	685,244		Feb 07 04:02 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 03 '25	Option Exercise	24.81	17,313	429,493	22,815	Feb 04 07:00 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 03 '25	Sale	101.80	17,313	1,762,507	5,502	Feb 04 07:00 PM
ARTHUR C BUTCHER	Officer	Feb 03 '25	Proposed Sale	101.80	17,313	1,762,506		Feb 03 04:02 PM
Sorenson John Bradley	EVP, Global Operations	Jan 01 '25	Option Exercise	0.00	4,469	0	41,565	Jan 03 04:33 PM
Sorenson John Bradley	EVP, Global Operations	Jan 02 '25	Sale	90.02	4,119	370,792	35,319	Jan 03 04:33 PM
Sorenson John Bradley	EVP, Global Operations	Jan 03 '25	Sale	89.86	2,342	210,449	32,977	Jan 03 04:33 PM
Mahoney Michael F	Chairman, President & CEO	Jan 01 '25	Option Exercise	0.00	57,121	0	1,578,326	Jan 03 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 01 '25	Option Exercise	0.00	10,430	0	38,884	Jan 03 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 03 '25	Sale	89.86	7,152	642,658	28,454	Jan 03 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jan 01 '25	Option Exercise	0.00	13,907	0	162,025	Jan 03 04:32 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Jan 01 '25	Option Exercise	0.00	8,940	0	9,918	Jan 03 04:32 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jan 01 '25	Option Exercise	0.00	6,456	0	40,866	Jan 03 04:32 PM
Brennan Daniel J.	EVP and CFO	Jan 01 '25	Option Exercise	0.00	14,901	0	238,822	Jan 03 04:32 PM
Brennan Daniel J.	EVP and CFO	Jan 03 '25	Sale	89.86	9,689	870,636	223,921	Jan 03 04:32 PM
JEFFREY B MIRVISS	Officer	Jan 03 '25	Proposed Sale	89.86	7,152	642,657		Jan 03 04:03 PM
JOHN B SORENSON	Officer	Jan 03 '25	Proposed Sale	89.86	2,342	210,449		Jan 03 04:02 PM
DANIEL BRENNAN	Officer	Jan 03 '25	Proposed Sale	89.86	9,689	870,635		Jan 03 04:00 PM
JOHN B SORENSON	Officer	Jan 02 '25	Proposed Sale	90.02	4,119	370,792		Jan 02 04:01 PM
Carruthers Wendy	EVP, Human Resources	Dec 02 '24	Option Exercise	19.31	4,263	82,306	36,291	Dec 04 04:13 PM
Carruthers Wendy	EVP, Human Resources	Dec 02 '24	Sale	90.78	6,983	633,917	29,308	Dec 04 04:13 PM
Woodworth Emily	SVP, Global Controller and CAO	Nov 27 '24	Sale	90.65	1,336	121,105	2,957	Dec 02 04:46 PM
WENDY CARRUTHERS	Officer	Dec 02 '24	Proposed Sale	90.78	6,983	633,917		Dec 02 04:02 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Nov 25 '24	Option Exercise	21.40	4,186	89,565	14,988	Nov 25 05:46 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Nov 25 '24	Sale	89.27	14,010	1,250,664	978	Nov 25 05:46 PM
ARTHUR C BUTCHER	Officer	Nov 25 '24	Proposed Sale	89.27	14,010	1,250,663		Nov 25 04:06 PM
LUDWIG EDWARD J	Director	Nov 21 '24	Sale	91.63	4,877	446,902	39,398	Nov 22 05:22 PM
LUDWIG EDWARD J	Director	Nov 21 '24	Proposed Sale	91.63	4,877	446,902		Nov 21 04:58 PM
Sorenson John Bradley	EVP, Global Operations	Nov 08 '24	Option Exercise	24.55	17,362	426,237	70,286	Nov 12 05:41 PM
Sorenson John Bradley	EVP, Global Operations	Nov 08 '24	Sale	87.66	30,580	2,680,572	39,706	Nov 12 05:41 PM
JOHN B SORENSON	Officer	Nov 08 '24	Proposed Sale	87.66	30,580	2,680,569		Nov 08 04:23 PM
Mahoney Michael F	Chairman, President & CEO	Nov 05 '24	Option Exercise	16.79	111,887	1,878,277	1,683,983	Nov 07 04:45 PM

Dollar change +0.17
Percentage change 0.26	%

Peers: ABT BDX MDT QGEN ILMN BIO DGX A RMD

| Held by: VTI VOO VO COWZ SPY IVV FTCS VTV RSP VOE

Index	S&P 500	P/E	20.40	EPS (ttm)	3.16	Insider Own	0.86%	Shs Outstand	225.56M	Perf Week	1.37%
Market Cap	14.47B	Forward P/E	13.87	EPS next Y	4.65	Insider Trans	-3.86%	Shs Float	222.47M	Perf Month	-9.41%
Income	744.00M	PEG	2.60	EPS next Q	1.02	Inst Own	103.12%	Short Float	2.66%	Perf Quarter	-18.15%
Sales	4.04B	P/S	3.58	EPS this Y	4.63%	Inst Trans	3.35%	Short Ratio	2.45	Perf Half Y	-20.29%
Book/sh	21.16	P/B	3.05	EPS next Y	8.89%	ROA	8.65%	Short Interest	5.93M	Perf Year	-13.53%
Cash/sh	8.79	P/C	7.34	EPS next 5Y	7.84%	ROE	15.78%	52W Range	62.69 - 84.67	Perf YTD	-10.54%
Dividend Est.	-	P/FCF	12.80	EPS past 5Y	-	ROI	10.24%	52W High	-23.83%	Beta	0.96
Dividend TTM	-	Quick Ratio	2.78	Sales past 5Y	6.10%	Gross Margin	55.94%	52W Low	2.86%	ATR (14)	1.61
Dividend Ex-Date	-	Current Ratio	3.49	EPS Y/Y TTM	50.25%	Oper. Margin	24.19%	RSI (14)	34.19	Volatility	1.87% 2.19%
Employees	7063	Debt/Eq	0.53	Sales Y/Y TTM	1.75%	Profit Margin	18.42%	Recom	2.48	Target Price	81.73
Option/Short	Yes / Yes	LT Debt/Eq	0.52	EPS Q/Q	-15.61%	Payout	0.00%	Rel Volume	0.92	Prev Close	64.32
Sales Surprise	0.00%	EPS Surprise	0.94%	Sales Q/Q	0.86%	Earnings	Feb 05 AMC	Avg Volume	2.41M	Price	64.49
SMA20	-4.77%	SMA50	-8.44%	SMA200	-15.58%	Trades		Volume	2,212,653	Change	0.26%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-06-25	Downgrade	Leerink Partners	Outperform → Market Perform	$80 → $75
Feb-03-25	Downgrade	Needham	Buy → Hold
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-10-24	Reiterated	Needham	Buy	$90
Dec-10-24	Initiated	Jefferies	Hold	$85
Oct-01-24	Downgrade	Citigroup	Buy → Neutral	$95 → $85
Jun-27-24	Initiated	Stephens	Overweight	$87
Apr-03-24	Upgrade	Citigroup	Neutral → Buy	$80 → $95
Jul-14-23	Upgrade	Needham	Hold → Buy	$95
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$75
Oct-13-22	Initiated	Mizuho	Buy	$75
Jul-20-22	Initiated	UBS	Neutral	$73
Jul-20-22	Downgrade	BofA Securities	Buy → Neutral	$81 → $75
Jul-18-22	Downgrade	BTIG Research	Buy → Neutral
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$75
Apr-04-22	Downgrade	Evercore ISI	Outperform → In-line	$80
Dec-15-21	Downgrade	Citigroup	Buy → Neutral	$85 → $78
Oct-15-21	Resumed	Cowen	Outperform	$83
Oct-14-21	Initiated	Redburn	Neutral
Jul-06-21	Upgrade	Evercore ISI	In-line → Outperform	$78

Show Previous Ratings

Feb-21-25 12:28PM	Hologic pockets CE mark for contrast biopsy software (Medical Device Network)
08:30AM	Do Options Traders Know Something About Hologic (HOLX) Stock We Don't? (Zacks)
Feb-20-25 05:23AM	BD business separation could allow competitors to rise in IVD test markets (Medical Device Network)
03:00AM	Hologic Obtains CE Mark for Affirm Contrast Biopsy Software (Business Wire)
Feb-19-25 05:16AM	FDA clears Hologics Aptima SARS-CoV-2 assay (Medical Device Network)
08:08AM	Loading…
Feb-18-25 08:08AM	Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay (Business Wire)
Feb-12-25 08:08AM	GE HealthCare Earnings: What To Look For From GEHC (StockStory)
Feb-11-25 09:15AM	Deciphering Hologic (HOLX) International Revenue Trends (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:12AM	QuidelOrtho Earnings: What To Look For From QDEL (StockStory)
Feb-07-25 09:40AM	Reddit initiated, Cigna downgraded: Wall Streets top analyst calls (TipRanks)
07:21AM	Why Hologic (HOLX) Stock Went Down On Thursday? (Insider Monkey)
Feb-06-25 09:50AM	Here's Why Hologic (HOLX) is a Strong Momentum Stock (Zacks) -10.10%
09:34AM	Analyst Report: Hologic, Inc. (Morningstar Research)
08:05AM	Q1 2025 Hologic Inc Earnings Call (Thomson Reuters StreetEvents)
02:13AM	Loading…
02:13AM	Hologic Inc (HOLX) Q1 2025 Earnings Call Highlights: Strong Diagnostics Growth Amid Breast ... (GuruFocus.com)
Feb-05-25 05:30PM	Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Hologic (HOLX) Q1 Earnings Surpass Estimates (Zacks)
04:11PM	Hologic: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:11PM	Hologic (NASDAQ:HOLX) Reports Q4 In Line With Expectations But Full-Year Sales Guidance Misses Expectations (StockStory)
04:01PM	Hologic Announces Financial Results for First Quarter of Fiscal 2025 (Business Wire)
Feb-04-25 09:40AM	Hologic (HOLX) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jan-31-25 09:15AM	Countdown to Hologic (HOLX) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Jan-29-25 10:01AM	Hologic (HOLX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-28-25 05:45PM	Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jan-22-25 05:45PM	Why Hologic (HOLX) Outpaced the Stock Market Today (Zacks)
Jan-21-25 08:00AM	New Report Reveals Alarming Decline in Womens Cancer Testing Worldwide (Business Wire)
Jan-20-25 09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Jan-16-25 06:38AM	Hologic receives FDA warning letter over Biozorb implantable markers (MedTech Dive)
05:45PM	Loading…
Jan-14-25 05:45PM	Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
Jan-12-25 04:00PM	Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025 (Business Wire)
Jan-08-25 05:45PM	Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
Jan-07-25 04:04PM	Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
09:00AM	Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? (Zacks)
Jan-06-25 04:15PM	Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 (Business Wire)
08:05AM	Hologic Completes Acquisition of Gynesonics, Inc. (Business Wire)
Jan-03-25 06:46AM	Hologic price target lowered to $76 from $81 at Evercore ISI (TipRanks)
Jan-02-25 05:45PM	Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Dec-26-24 05:45PM	Hologic (HOLX) Flat As Market Sinks: What You Should Know (Zacks)
Dec-24-24 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Dec-23-24 12:19PM	Analyst Report: Hologic, Inc. (Morningstar Research)
Dec-19-24 05:45PM	Here's Why Hologic (HOLX) Fell More Than Broader Market (Zacks)
06:45AM	Hologic agrees with CDC to develop reagents for H5N1 bird flu testing (Medical Device Network)
Dec-18-24 08:08AM	Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC (Business Wire)
Dec-14-24 06:50AM	Hologic initiated with a Peer Perform at Wolfe amid near-term headwinds (TipRanks)
Dec-13-24 07:10PM	Analyst Report: Hologic, Inc. (Morningstar Research)
05:45PM	Hologic (HOLX) Stock Moves -1.93%: What You Should Know (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Dec-10-24 11:10PM	Why Is Hologic Inc. (HOLX) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? (Insider Monkey)
04:01PM	Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines (Business Wire)
Dec-09-24 04:05PM	Martin Madaus Elected to Hologic Board of Directors (Business Wire)
08:05AM	New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence (Business Wire)
Dec-04-24 11:30AM	Hologic (HOLX) Down 1.7% Since Last Earnings Report: Can It Rebound? (Zacks)
Dec-02-24 01:29PM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
08:08AM	Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations (Business Wire)
Nov-25-24 08:22AM	Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024 (Business Wire)
Nov-19-24 09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Nov-14-24 08:08AM	Hologic to Webcast Presentations at Upcoming Investor Conferences (Business Wire)
Nov-08-24 12:21PM	Implied Volatility Surging for Hologic (HOLX) Stock Options (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-05-24 11:43AM	Analyst Report: Hologic, Inc. (Morningstar Research) -5.88%
06:35AM	Q4 2024 Hologic Inc Earnings Call (Thomson Reuters StreetEvents)
02:06AM	Hologic Inc (HOLX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Challenges (GuruFocus.com)
Nov-04-24 05:30PM	Hologic (HOLX) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:15PM	Hologic (HOLX) Q4 Earnings Miss Estimates (Zacks)
04:20PM	Hologic: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024 (Business Wire)
Oct-30-24 09:15AM	Unlocking Q4 Potential of Hologic (HOLX): Exploring Wall Street Estimates for Key Metrics (Zacks)
Oct-28-24 05:45PM	Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
10:01AM	Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
06:18AM	FDA advises clinicians to stop using Hologic radiographic markers (MedTech Dive)
Oct-25-24 02:57PM	Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints (Benzinga)
Oct-23-24 09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
06:00AM	Hologic to lay off 86 people in closure of Connecticut facility (MedTech Dive)
Oct-21-24 05:45PM	Hologic (HOLX) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Oct-15-24 05:45PM	Hologic (HOLX) Gains As Market Dips: What You Should Know (Zacks)
08:05AM	Hologic to buy Gynesonics for $350M to acquire fibroid system (MedTech Dive)
07:32AM	Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women (PR Newswire)
07:02AM	Hologic to acquire Gynesonics to strengthen womens health portfolio (Medical Device Network)
Oct-14-24 02:07PM	Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments (Benzinga)
08:05AM	Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Womens Health (Business Wire)
Oct-11-24 09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
Oct-09-24 12:10PM	Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Oct-08-24 05:45PM	Hologic (HOLX) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
Oct-04-24 08:22AM	Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 (Business Wire)
Oct-02-24 05:45PM	Hologic (HOLX) Stock Sinks As Market Gains: Here's Why (Zacks)
Oct-01-24 09:36AM	Hologic CEO Steve MacMillan on breast cancer detection, future of AI-powered diagnostics (CNBC TV)
Sep-30-24 09:17AM	Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month (Business Wire)
09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Sep-26-24 05:45PM	Hologic (HOLX) Gains But Lags Market: What You Should Know (Zacks)
Sep-24-24 09:40AM	Here's Why Hologic (HOLX) is a Strong Value Stock (Zacks)
Sep-20-24 05:45PM	Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
Sep-17-24 09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Sep-11-24 09:50AM	Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term (Zacks)
Sep-06-24 09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Sep-02-24 09:40AM	Why Hologic (HOLX) is a Top Value Stock for the Long-Term (Zacks)
Aug-29-24 08:08AM	Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire)
Aug-28-24 11:30AM	Why Is Hologic (HOLX) Down 3.4% Since Last Earnings Report? (Zacks)
Aug-26-24 09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mitchell Essex D	Chief Operating Officer	Dec 04 '24	Option Exercise	62.60	22,902	1,433,659	52,813	Dec 06 04:28 PM
Mitchell Essex D	Chief Operating Officer	Dec 04 '24	Sale	76.34	24,856	1,897,482	27,957	Dec 06 04:28 PM
Mitchell Essex D	Officer	Dec 04 '24	Proposed Sale	76.34	24,856	1,897,484		Dec 04 12:24 PM
Oberton Karleen Marie	Chief Financial Officer	Aug 29 '24	Option Exercise	40.95	32,805	1,343,214	136,721	Sep 03 04:15 PM
Oberton Karleen Marie	Chief Financial Officer	Aug 29 '24	Sale	80.56	52,679	4,243,662	84,042	Sep 03 04:15 PM
Oberton Karleen Marie	Officer	Aug 29 '24	Proposed Sale	80.56	52,679	4,243,657		Aug 29 04:36 PM
Schnittker Brandon	Div. President, GYN Surgical	Aug 06 '24	Sale	83.11	476	39,559	3,735	Aug 08 04:08 PM
Schnittker Brandon	Officer	Aug 06 '24	Proposed Sale	83.11	476	39,559		Aug 06 04:48 PM
COHN BENJAMIN JORDAN	Principal Accounting Officer	Aug 01 '24	Sale	81.99	5,093	417,570	10,476	Aug 05 04:29 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 30 '24	Option Exercise	26.21	44,039	1,154,262	1,201,601	Aug 01 04:09 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 30 '24	Sale	81.70	44,039	3,597,924	1,157,562	Aug 01 04:09 PM
COHN BENJAMIN JORDAN	Officer	Aug 01 '24	Proposed Sale	81.99	5,093	417,574		Aug 01 03:58 PM
MACMILLAN STEPHEN P	Officer	Jul 30 '24	Proposed Sale	81.70	44,039	3,597,894		Jul 30 04:29 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 17 '24	Option Exercise	26.21	3,672	96,243	1,161,234	Jul 19 04:09 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Jul 17 '24	Sale	80.13	3,672	294,223	1,157,562	Jul 19 04:09 PM
Stamoulis Christiana	Director	Jul 17 '24	Option Exercise	26.74	9,039	241,703	54,511	Jul 19 04:06 PM
Stamoulis Christiana	Director	Jul 17 '24	Sale	79.50	9,039	718,600	45,472	Jul 19 04:06 PM
GARRETT SCOTT T	Director	Mar 14 '24	Option Exercise	30.93	16,441	508,471	65,052	Mar 15 04:11 PM
GARRETT SCOTT T	Director	Mar 14 '24	Sale	75.50	16,441	1,241,296	48,611	Mar 15 04:11 PM
Dockendorff Charles J	Director	Mar 08 '24	Sale	76.21	1,465	111,648	1,572	Mar 11 06:45 PM
CRAWFORD SALLY	Director	Mar 08 '24	Option Exercise	26.74	9,039	241,703	141,966	Mar 11 06:41 PM
CRAWFORD SALLY	Director	Mar 08 '24	Sale	76.40	9,039	690,607	132,927	Mar 11 06:41 PM

Dollar change -0.43
Percentage change -0.68	%

Peers: ABT BDX BAX EW MDT HOLX STE BSX TFX XRAY

| Held by: VTI IJH VB IWM VXF VBK IWO MDY VTWO SCHA

Index	RUT	P/E	24.80	EPS (ttm)	2.54	Insider Own	1.13%	Shs Outstand	50.24M	Perf Week	1.17%
Market Cap	3.17B	Forward P/E	12.63	EPS next Y	4.99	Insider Trans	0.00%	Shs Float	49.67M	Perf Month	-14.08%
Income	130.06M	PEG	1.88	EPS next Q	1.22	Inst Own	113.59%	Short Float	10.55%	Perf Quarter	-28.52%
Sales	1.37B	P/S	2.31	EPS this Y	14.78%	Inst Trans	-2.10%	Short Ratio	6.64	Perf Half Y	-14.92%
Book/sh	18.05	P/B	3.49	EPS next Y	9.76%	ROA	5.50%	Short Interest	5.24M	Perf Year	-11.77%
Cash/sh	6.39	P/C	9.87	EPS next 5Y	13.16%	ROE	14.06%	52W Range	58.80 - 97.97	Perf YTD	-19.29%
Dividend Est.	1.00 (1.59%)	P/FCF	33.00	EPS past 5Y	17.09%	ROI	6.12%	52W High	-35.67%	Beta	0.42
Dividend TTM	-	Quick Ratio	2.55	Sales past 5Y	6.80%	Gross Margin	51.09%	52W Low	7.18%	ATR (14)	2.82
Dividend Ex-Date	-	Current Ratio	3.97	EPS Y/Y TTM	2.55%	Oper. Margin	15.62%	RSI (14)	38.37	Volatility	3.18% 4.14%
Employees	3657	Debt/Eq	1.35	Sales Y/Y TTM	8.14%	Profit Margin	9.47%	Recom	1.45	Target Price	96.80
Option/Short	Yes / Yes	LT Debt/Eq	1.35	EPS Q/Q	21.92%	Payout	0.00%	Rel Volume	1.25	Prev Close	63.45
Sales Surprise	-1.19%	EPS Surprise	1.37%	Sales Q/Q	3.66%	Earnings	Feb 06 BMO	Avg Volume	788.96K	Price	63.02
SMA20	-3.70%	SMA50	-13.82%	SMA200	-21.55%	Trades		Volume	986,273	Change	-0.68%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-07-25	Downgrade	BofA Securities	Neutral → Underperform	$95 → $68
Dec-06-24	Initiated	JP Morgan	Overweight	$116
Nov-08-24	Upgrade	Raymond James	Outperform → Strong Buy	$120
Sep-13-24	Initiated	CL King	Buy	$116
Sep-11-24	Initiated	BofA Securities	Neutral	$85
Sep-10-24	Initiated	BTIG Research	Buy	$112
Jun-12-24	Upgrade	Needham	Hold → Buy	$112
Oct-13-22	Initiated	Mizuho	Buy	$90
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral	$75 → $59
Aug-17-21	Resumed	Raymond James	Outperform	$75
Jun-17-21	Initiated	Citigroup	Buy	$75
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform	$140
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$106
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform

Show Previous Ratings

Feb-09-25 08:02AM	Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-07-25 02:07AM	Haemonetics Corp (HAE) Q3 2025 Earnings Call Highlights: Strong Hospital Growth Amid Plasma ... (GuruFocus.com) -5.79%
Feb-06-25 09:30AM	Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -11.58%
07:40AM	Haemonetics (HAE) Q3 Earnings Meet Estimates (Zacks)
06:39AM	Haemonetics: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:37AM	Loading…
06:37AM	Haemonetics Narrows FY25 Adj. EPS Outlook Range, But Trims Revenue Growth - Update (RTT News)
06:28AM	Haemonetics (NYSE:HAE) Misses Q4 Revenue Estimates (StockStory)
06:00AM	Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
Feb-05-25 08:03AM	Earnings To Watch: Haemonetics (HAE) Reports Q4 Results Tomorrow (StockStory)
07:07AM	Haemonetics Corp (HAE) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Jan-24-25 09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Jan-14-25 06:13AM	Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A (PR Newswire)
Jan-08-25 05:03PM	Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025 (PR Newswire)
09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Jan-06-25 06:00AM	Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
09:35AM	Loading…
Dec-23-24 09:35AM	Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE) (Zacks)
Dec-06-24 09:40AM	Are Investors Undervaluing Haemonetics (HAE) Right Now? (Zacks)
Dec-04-24 09:55AM	Wall Street Analysts See a 27.84% Upside in Haemonetics (HAE): Can the Stock Really Move This High? (Zacks)
06:22AM	Haemonetics to offload whole-blood business for up to $67M (MedTech Dive)
Dec-03-24 01:16AM	Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A (PR Newswire)
Nov-14-24 05:35AM	Haemonetics to close California facility, lay off 75 people (MedTech Dive)
Nov-12-24 04:12PM	Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
Nov-11-24 09:55AM	Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet (Zacks)
Nov-07-24 09:30AM	Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics (Zacks) +10.71%
07:25AM	Haemonetics (HAE) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:26AM	Haemonetics: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
Nov-06-24 09:15AM	Haemonetics (HAE) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
07:09AM	Haemonetics Corp (HAE) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
10:01AM	Loading…
Oct-31-24 10:01AM	Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-09-24 05:28PM	Haemonetics Corp (HAE) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Oct-03-24 04:05PM	Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024 (PR Newswire)
Sep-24-24 08:00AM	Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer (GlobeNewswire)
Sep-20-24 12:54AM	Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 (Insider Monkey)
Sep-02-24 09:35AM	After Plunging -15.88% in 4 Weeks, Here's Why the Trend Might Reverse for Haemonetics (HAE) (Zacks)
Aug-23-24 09:22AM	Implied Volatility Surging for Haemonetics (HAE) Stock Options (Zacks)
Aug-16-24 09:08AM	Haemonetics (HAE) Set to Launch VASCADE MVP XL in US (Zacks)
06:33AM	Haemonetics Vascade MVP XL vascular closure system enters US market (Medical Device Network)
Aug-15-24 06:30AM	Haemonetics Announces Full Market Release for VASCADE MVP XL Vascular Closure System (PR Newswire)
Aug-12-24 07:47AM	Haemonetics (HAE) Q1 Earnings Miss Estimates, Gross Margin Rises (Zacks)
Aug-09-24 09:40AM	Is Haemonetics (HAE) Stock Undervalued Right Now? (Zacks)
09:35AM	Down -14.6% in 4 Weeks, Here's Why Haemonetics (HAE) Looks Ripe for a Turnaround (Zacks)
Aug-08-24 07:25AM	Haemonetics (HAE) Misses Q1 Earnings Estimates (Zacks) -10.84%
06:25AM	Haemonetics: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website (PR Newswire)
Aug-07-24 09:55AM	Wall Street Analysts See a 30.13% Upside in Haemonetics (HAE): Can the Stock Really Move This High? (Zacks)
09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
Aug-01-24 07:00AM	Sotera Health Appoints Christopher Simon to the Board of Directors (GlobeNewswire)
Jul-30-24 06:00AM	Haemonetics Announces CE Mark Certification for the SavvyWire Pre-Shaped Pressure Guidewire (PR Newswire)
Jul-29-24 10:20AM	Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings (Zacks)
Jul-16-24 09:45AM	Here's Why Haemonetics (HAE) is a Strong Growth Stock (Zacks)
Jul-12-24 11:38AM	Haemonetics (HAE) Banks on Growing Hospital Arm, New Launches (Zacks)
Jul-10-24 09:55AM	Wall Street Analysts Think Haemonetics (HAE) Could Surge 33.2%: Read This Before Placing a Bet (Zacks)
Jul-08-24 04:05PM	Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024 (PR Newswire)
Jun-27-24 09:35AM	Haemonetics (HAE) Loses -5.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jun-19-24 01:26PM	Haemonetics (HAE) Expands VASCADE Line With New Limited Launch (Zacks)
04:52AM	Haemonetics launches VASCADE MVP XL device for venous closure (Medical Device Network)
Jun-18-24 04:15PM	Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure Device (PR Newswire)
Jun-14-24 09:40AM	Haemonetics (HAE) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jun-13-24 10:19AM	Haemonetics (HAE) Banks on Growing Plasma Arm, Innovation (Zacks)
Jun-03-24 09:45AM	Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term (Zacks)
May-30-24 02:41AM	Insider Sale: President of Global Hospital at Haemonetics Corp (HAE) Sells Shares (GuruFocus.com)
02:41AM	Insider Sale: EVP and General Counsel Michelle Basil Sells 12,990 Shares of Haemonetics Corp (HAE) (GuruFocus.com)
May-29-24 09:40AM	Here's Why Haemonetics (HAE) is a Strong Value Stock (Zacks)
May-27-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Haemonetics (HAE) (Zacks)
May-24-24 09:55AM	Wall Street Analysts Believe Haemonetics (HAE) Could Rally 26.58%: Here's is How to Trade (Zacks)
May-23-24 12:00PM	Haemonetics (HAE) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
06:00AM	Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes (PR Newswire)
May-22-24 09:13AM	Here's Why You Should Buy Haemonetics (HAE) Stock Now (Zacks)
02:06AM	Insider Sale: EVP Josep Llorens Sells Shares of Haemonetics Corp (HAE) (GuruFocus.com)
May-21-24 04:05PM	Haemonetics Announces Proposed Convertible Senior Notes Offering (PR Newswire)
May-17-24 12:00PM	Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid (Zacks)
10:20AM	Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue? (Zacks)
May-14-24 09:15AM	Haemonetics Corporation (HAE) Hit a 52 Week High, Can the Run Continue? (Zacks)
May-13-24 09:40AM	Why Haemonetics (HAE) is a Top Value Stock for the Long-Term (Zacks)
May-10-24 03:57PM	Haemonetics Corporation (NYSE:HAE) Q4 2024 Earnings Call Transcript (Insider Monkey)
12:41PM	Haemonetics Corp (HAE) Fiscal 2024 Earnings: Aligns with EPS Projections, Reveals Robust ... (GuruFocus.com)
10:53AM	Haemonetics (HAE) Q4 Earnings Top Estimates, Margins Expand (Zacks)
10:37AM	Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating (MT Newswires)
May-09-24 10:55AM	HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024 (InvestorPlace)
09:30AM	Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:20AM	Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates (Zacks)
06:39AM	Haemonetics' Fiscal Q4 Adjusted Earnings, Revenue Rise (MT Newswires)
06:28AM	Haemonetics: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:00AM	Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website (PR Newswire)
May-08-24 09:15PM	Insider Sale at Haemonetics Corp (HAE): EVP, Chief Technology Officer Anila Lingamneni Sells ... (GuruFocus.com)
May-06-24 09:16AM	Exploring Analyst Estimates for Haemonetics (HAE) Q4 Earnings, Beyond Revenue and EPS (Zacks)
May-01-24 11:51AM	Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs (Zacks)
Apr-12-24 09:03AM	Why You Should Add Haemonetics (HAE) to Your Portfolio Now (Zacks)
Apr-10-24 04:58PM	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 (PR Newswire)
Apr-08-24 03:20PM	Royce Investment Partners Commentary: What Will Fuel Small-Cap Returns? (GuruFocus.com)
Apr-05-24 09:48AM	Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval (Zacks)
Apr-04-24 06:30AM	Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge (PR Newswire)
Apr-01-24 08:00AM	Haemonetics Corporation Completes Acquisition of Attune Medical (PR Newswire)
Mar-29-24 09:30AM	Haemonetics (HAE) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
Mar-11-24 09:30AM	Haemonetics (HAE) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Mar-06-24 06:54AM	Haemonetics (HAE) Signs Agreement to Acquire Attune Medical (Zacks)
Mar-05-24 06:18AM	Haemonetics to buy Attune Medical for $160M (MedTech Dive)
06:00AM	Haemonetics Announces Definitive Agreement to Acquire Attune Medical (PR Newswire)

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lingamneni Anila	Former Officer	Nov 11 '24	Proposed Sale	90.68	6,238	565,692		Nov 12 11:26 AM
Strong Stewart W	President, Global Hospital	Jul 26 '24	Sale	91.15	4,312	393,039	18,196	Jul 29 05:03 PM
Strong Stewart W	Officer	Jul 26 '24	Proposed Sale	91.15	4,312	393,039		Jul 26 09:47 AM
Lingamneni Anila	EVP, Chief Technology Officer	Jul 11 '24	Sale	90.00	2,136	192,240	21,410	Jul 15 04:27 PM
Lingamneni Anila	EVP, Chief Technology Officer	Jul 12 '24	Sale	90.00	79	7,110	21,331	Jul 15 04:27 PM
Simon, Christopher	President & CEO	Jun 06 '24	Option Exercise	41.64	104,516	4,352,046	433,877	Jun 07 04:15 PM
Basil Michelle L	EVP and General Counsel	May 29 '24	Sale	88.08	12,990	1,144,208	31,257	May 29 05:38 PM
Strong Stewart W	President, Global Hospital	May 29 '24	Sale	87.53	8,857	775,253	18,196	May 29 05:27 PM
Strong Stewart W	President, Global Hospital	May 20 '24	Option Exercise	56.57	2,241	126,773	20,437	May 21 06:01 PM
Strong Stewart W	President, Global Hospital	May 20 '24	Sale	95.11	686	65,245	18,196	May 21 06:01 PM
Llorens Josep	EVP, Global Manufacturing	May 20 '24	Sale	95.08	987	93,844	21,310	May 21 05:52 PM
Llorens Josep	EVP, Global Manufacturing	May 17 '24	Sale	94.82	822	77,942	16,350	May 21 05:52 PM
Basil Michelle L	EVP and General Counsel	May 20 '24	Sale	95.08	1,604	152,508	31,257	May 21 05:46 PM
Basil Michelle L	EVP and General Counsel	May 17 '24	Sale	95.00	1,073	101,935	29,352	May 21 05:46 PM
Strong Stewart W	President, Global Hospital	May 16 '24	Option Exercise	57.60	2,410	138,816	18,018	May 17 05:11 PM
Strong Stewart W	President, Global Hospital	May 16 '24	Sale	96.04	733	70,397	15,608	May 17 05:11 PM
Basil Michelle L	EVP and General Counsel	May 16 '24	Sale	96.14	985	94,698	30,425	May 17 05:02 PM
Llorens Josep	EVP, Global Manufacturing	May 16 '24	Sale	96.14	770	74,028	17,172	May 17 04:55 PM
Lingamneni Anila	EVP, Chief Technology Officer	May 06 '24	Sale	95.00	2,305	218,975	12,295	May 08 04:21 PM

BSX

Boston Scientific Corp

HOLX

Hologic, Inc

HAE

Haemonetics Corp

Upgrade your FINVIZ experience